Verndari has a total of 29 patents globally, out of which 4 have been granted. Of these 29 patents, more than 82% patents are active. The United States of America and China is where Verndari has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Verndari.
Verndari was founded in 2015. Verndari is a company that specializes in influenza vaccinations. An innovative method for producing the influenza vaccine antigen in mammalian cells has been devised. The use of FDA-approved surrogate indicators of potency and efficacy is permitted with this influenza vaccination. Rapid clinical trial efficacy demonstration and manufacturing capacity development are made possible by these surrogate indicators.
Do read about some of the most popular patents of Verndari which have been covered by us in this article and also you can find Verndari patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Verndari patent portfolio.
How many patents does Verndari have?
Verndari has a total of 29 patents globally. These patents belong to 5 unique patent families. Out of 29 patents, 24 patents are active.
How Many Patents did Verndari File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Verndari Applications Filed | Verndari Patents Granted |
| 2023 | 1 | 1 |
| 2022 | 4 | – |
| 2021 | – | 1 |
| 2020 | 7 | – |
| 2019 | 1 | 1 |
| 2018 | 2 | 1 |
| 2017 | 14 | – |
How many Verndari patents are Alive/Dead?
Worldwide Patents
How Many Patents did Verndari File in Different Countries?
Countries in which Verndari Filed Patents
| Country | Patent |
| United States Of America | 5 |
| China | 5 |
| India | 3 |
| Australia | 3 |
| Europe | 3 |
| Canada | 2 |
| Japan | 2 |
| Hong Kong (S.A.R.) | 1 |
| Brazil | 1 |
Where are Research Centers of Verndari Patents Located?
The Research Centers of Verndari Patents is the United States of America.
Best Verndari Patents
WO2017123652A1 is the most popular patent in the Verndari portfolio. It has received 12 citations so far from company like Vaxxas Pty.
Below is the list of most cited patents of Verndari:
| Publication Number | Citation Count |
| WO2017123652A1 | 12 |
| WO2021022008A1 | 11 |
| WO2018026955A1 | 6 |
| CA3149390A1 | 3 |
| US20190184366A1 | 2 |
| US10022436B2 | 1 |
| WO2023043933A1 | 1 |
What Percentage of Verndari US Patent Applications Were Granted?
Verndari (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 100%.
Below are the key stats of Verndari patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Verndari?
| Law Firm | Total Applications | Success Rate |
| Wilson Sonsini Goodrich & Rosati | 100% |
List of Verndari patents
| Publication Number | Title |
| US10363303B2 | Microneedle Compositions And Methods Of Using Same |
| US10022436B2 | Microneedle Compositions And Methods Of Using Same |
| US20230000974A1 | Virus-Like Particle Vaccines |
| US20220280633A1 | Virus-Like Particle Vaccines |
| US20190184366A1 | Microarrays And Methods |
| EP4004036A1 | Virus-Like Particle Vaccines |
| EP3493872A4 | Microarrays And Methods |
| EP3402549A4 | Microneedle Compositions And Methods Of Using Same |
| CN109862936B | Microarrays And Methods |
| CN108778365B | Microneedle Compositions And Methods Of Use Thereof |
| CN116726371A | Microarrays And Methods |
| CN114729030A | Virus-Like Particle Vaccine |
| CN113181106A | Micro-Needle Compositions And Methods Of Using Same |
| WO2023043933A1 | Stabilized Lipid Nanoparticle Mrna Compositions And Uses Thereof |
| AU2022201834A1 | Microneedle Compositions And Methods Of Using Same |
| AU2020321021A1 | Virus-Like Particle Vaccines |
| JP2022543046A5 | Virus-Like Particle Vaccine |
| IN202217010231A | Virus-Like Particle Vaccines |
| CA3149390A1 | Virus-Like Particle Vaccines |
| IN201917007932A | Microarrays And Methods |
| IN201817027326A | Microneedle Compositions And Methods Of Using Same |
| CA3010974A1 | Microneedle Compositions And Methods Of Using Same |
| BR112018014109A2 | Microneedle Compositions And Methods Of Use Thereof |
| HK40079920A | Virus-Like Particle Vaccines |
| WO2021022008A1 | Virus-Like Particle Vaccines |
| WO2018026955A1 | Microarrays And Methods |
| WO2017123652A1 | Microneedle Compositions And Methods Of Using Same |
| AU2017207744A1 | Microneedle Compositions And Methods Of Using Same |
| JP2019511255A5 | Microneedle Composition And Method Of Using Same |
What are Verndari key innovation segments?
What Technologies are Covered by Verndari?
The chart below distributes patents filed by Verndari